An insight of rapamycin against cadmium's neurotoxicity

Oncotarget

Volumn 8, Issue 6, 2017, Pages 9013-9014

  Xu, Chong ^a   Huang, Shile ^a   Chen, Long ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Cadmium; Erk1 2; JNK; Neuronal cells; Neuroscience; PP2A; Rapamycin; ROS

Indexed keywords

CADMIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; BIOACCUMULATION; BLOOD BRAIN BARRIER; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUNTINGTON CHOREA; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 85012005553     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.14872     Document Type: Editorial

References (8)

1. Monroe RK, and Halvorsen SW. Free Radic. Biol. Med. 2006; 41:493-502.
2. Bove J, et al. Nat. Rev. Neurosci. 2011; 12:437-452.
3. Chen L, et al. J. Neurochem. 2008; 105:251-261.
4. Chen L, et al. Free Radic. Biol. Med. 2011; 50:624-632.
5. Chen S, et al. Neuropathol. Appl. Neurobiol. 2014; 40:759-777.
6. Chen L, et al. Free Radic. Biol. Med. 2008; 45:1035-1044.
7. Huang S, et al. Mol. Cell. 2003; 11:1491-1501.
8. Xu C, et al. Neuropharmacology. 2016; 105:270-284.